ITRM logo

Iterum Therapeutics (ITRM) Cash From Financing

Annual CFF

$26.69 M
+$25.66 M+2481.33%

December 31, 2024


Summary


Performance

ITRM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMcash flowmetrics:

Quarterly CFF

$13.88 M
+$8.45 M+155.56%

December 1, 2024


Summary


Performance

ITRM Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMcash flowmetrics:

TTM CFF

$26.69 M
+$13.29 M+99.14%

December 1, 2024


Summary


Performance

ITRM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ITRM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2481.3%+155.6%+99.1%
3 y3 years-67.9%+155.6%+99.1%
5 y5 years+1193.8%+155.6%+99.1%

ITRM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-67.9%+1568.2%at high+716.5%-67.9%+537.1%
5 y5-year-67.9%+1568.2%-84.0%+716.5%-74.7%+537.1%
alltimeall time-78.2%+1568.2%-84.3%+716.5%-78.2%+537.1%

Iterum Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$26.69 M(+2481.3%)
-
-
Dec 2024
-
$13.88 M(+155.6%)
$26.69 M(+99.1%)
Sep 2024
-
$5.43 M(+3151.5%)
$13.40 M(+67.9%)
Jun 2024
-
$167.00 K(-97.7%)
$7.98 M(-0.4%)
Mar 2024
-
$7.22 M(+1125.3%)
$8.02 M(+675.2%)
Dec 2023
$1.03 M(-156.9%)
$589.00 K(+5790.0%)
$1.03 M(+17.8%)
Sep 2023
-
$10.00 K(-95.0%)
$878.00 K(+1.2%)
Jun 2023
-
$200.00 K(-14.9%)
$868.00 K(+29.9%)
Mar 2023
-
$235.00 K(-45.7%)
$668.00 K(-136.7%)
Dec 2022
-$1.82 M(-102.2%)
$433.00 K(>+9900.0%)
-$1.82 M(-53.1%)
Sep 2022
-
$0.00(0.0%)
-$3.88 M(-29.6%)
Jun 2022
-
$0.00(-100.0%)
-$5.51 M(-9.7%)
Mar 2022
-
-$2.25 M(+38.2%)
-$6.11 M(-107.3%)
Dec 2021
$83.13 M(+28.9%)
-$1.63 M(-0.3%)
$83.13 M(-16.8%)
Sep 2021
-
-$1.63 M(+176.0%)
$99.88 M(-2.3%)
Jun 2021
-
-$592.00 K(-100.7%)
$102.28 M(-3.1%)
Mar 2021
-
$86.98 M(+475.0%)
$105.59 M(+63.8%)
DateAnnualQuarterlyTTM
Dec 2020
$64.47 M(+3025.3%)
$15.13 M(+1872.2%)
$64.47 M(+33.4%)
Sep 2020
-
$767.00 K(-71.7%)
$48.31 M(-4.5%)
Jun 2020
-
$2.71 M(-94.1%)
$50.59 M(+5.6%)
Mar 2020
-
$45.87 M(-4536.3%)
$47.88 M(+2221.1%)
Dec 2019
$2.06 M(-98.3%)
-$1.03 M(-134.0%)
$2.06 M(-53.8%)
Sep 2019
-
$3.04 M(>+9900.0%)
$4.47 M(+212.7%)
Jun 2019
-
$10.00 K(-79.6%)
$1.43 M(-98.4%)
Mar 2019
-
$49.00 K(-96.4%)
$90.08 M(-26.3%)
Dec 2018
$122.20 M(+166.4%)
$1.37 M(>+9900.0%)
$122.20 M(+1.1%)
Sep 2018
-
$0.00(-100.0%)
$120.83 M(0.0%)
Jun 2018
-
$88.66 M(+175.5%)
$120.83 M(+54.8%)
Mar 2018
-
$32.18 M(>+9900.0%)
$78.04 M(+70.2%)
Dec 2017
$45.87 M(+120.0%)
$0.00(0.0%)
$45.87 M(0.0%)
Sep 2017
-
$0.00(-100.0%)
$45.87 M(0.0%)
Jun 2017
-
$45.87 M(>+9900.0%)
$45.87 M(>+9900.0%)
Mar 2017
-
$0.00
$0.00
Dec 2016
$20.85 M
-
-

FAQ

  • What is Iterum Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Iterum Therapeutics?
  • What is Iterum Therapeutics annual CFF year-on-year change?
  • What is Iterum Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Iterum Therapeutics?
  • What is Iterum Therapeutics quarterly CFF year-on-year change?
  • What is Iterum Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Iterum Therapeutics?
  • What is Iterum Therapeutics TTM CFF year-on-year change?

What is Iterum Therapeutics annual cash flow from financing activities?

The current annual CFF of ITRM is $26.69 M

What is the all time high annual CFF for Iterum Therapeutics?

Iterum Therapeutics all-time high annual cash flow from financing activities is $122.20 M

What is Iterum Therapeutics annual CFF year-on-year change?

Over the past year, ITRM annual cash flow from financing activities has changed by +$25.66 M (+2481.33%)

What is Iterum Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of ITRM is $13.88 M

What is the all time high quarterly CFF for Iterum Therapeutics?

Iterum Therapeutics all-time high quarterly cash flow from financing activities is $88.66 M

What is Iterum Therapeutics quarterly CFF year-on-year change?

Over the past year, ITRM quarterly cash flow from financing activities has changed by +$8.45 M (+155.56%)

What is Iterum Therapeutics TTM cash flow from financing activities?

The current TTM CFF of ITRM is $26.69 M

What is the all time high TTM CFF for Iterum Therapeutics?

Iterum Therapeutics all-time high TTM cash flow from financing activities is $122.20 M

What is Iterum Therapeutics TTM CFF year-on-year change?

Over the past year, ITRM TTM cash flow from financing activities has changed by +$13.29 M (+99.14%)